Makale
Tam Makale
Uluslararası
2017
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma
European Journal of Pharmaceutical Sciences
Cilt 109 · ss. 402–411 · 15.11.2017
Özet
Glioblastoma is one of the most aggressive malignant primary brain cancer in adults. To date, surgery, radiotherapy and current pharmacological treatments are not sufficient to manage this pathology that has a high mortality rate (median survival 12-15 months).
Anahtar kelimeler
GLIOBLASTOMA
Memantine
Histone deacetylase
Mutual prodrug
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
Atıf için künye
CACCIATORE, I., Fornasari, E., MARINELLI, L., EUSEPI, P., CIULLA, M., Ozdemir, O., Tatar, A., Türkez, H., & DI STEFANO, A. (2017). Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma. European Journal of Pharmaceutical Sciences, 109, 402–411. https://doi.org/10.1016/j.ejps.2017.08.030
BibTeX
@article{cacciatore2017-233371,
author = {CACCIATORE, Ivana and Fornasari, Erika and MARINELLI, Lisa and EUSEPI, Piera and CIULLA, Michele and Ozdemir, Ozlem and Tatar, Abdulgani and Türkez, Hasan and DI STEFANO, Antonio},
title = {Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma},
journal = {European Journal of Pharmaceutical Sciences},
year = {2017},
volume = {109},
pages = {402--411},
issn = {0928-0987},
doi = {10.1016/j.ejps.2017.08.030},
url = {https://akademik.atauni.edu.tr/yayinlar/233371-memantine-derived-drugs-as-potential-antitumor-agents-for-the-treatment-of}
}